ENETS Research - Recruiting Projects

After a thorough selection process, ENETS Advisory Board has approved several research initiatives addressing so far unmet medical needs. ENETS is supporting the following trials, which are still recruiting.

ASPEN Study - Asymptomatic Small Pancreatic Endocrine Neoplasms.

A prospective evaluation of the management of Asymptomatic Sporadic nonfunctioning Pancreatic neuroEndocrine Neoplasms ≤ 2 cm


The ongoing trial (SEQTOR) is currently investigating the antiproliferative efficacy and safety of everolimus, followed by STZ/5‐FU in advanced pancreatic NET (pNET) in a crossover design upon progression

Important Notice:

In preparation of the upcoming 16th Annual ENETS Conference, 6 to 8 March 2019 in Barcelona, Spain, we have discovered in the world wide web at least one professional entity suggestive of possessing an ENETS mandate for conference registrations. Therefore, we must inform you that 100% of all conference participants are registered through ENETS official website www.enets.org and http://enetsconference.org/. There are no further options to validly register for Barcelona 2019 (or for any other ENETS event).

Please stay away from fraudulent scams abusing the ENETS acronym to register – and charge you above official ENETS conference fees! Such entities, against whom ENETS presses criminal charges, are neither authorized, nor commissioned nor instructed by ENETS to make such representations.